28 October 2026

Targeted Therapy ✅

📋 KEY NURSING CONSIDERATIONS

Consider the need for assessment, information provision, support or management on the following topics:  

Advance care planning Introduce and support the patient with the advance care planning process. Advance care planning is a process that enables individuals to plan for future care by documenting their values, goals and preferences for medical treatment in the event that they lose decision-making capacity.

Bleeding risk Educate the patient regarding bleeding risk associated with systemic therapy. Systemic therapy can increase bleeding risk by disrupting blood vessel formation or reducing platelet counts, with angiogenesis inhibitors associated with the highest risk, particularly for gastrointestinal (GI) bleeding.

Body image Assess and discuss the impact of a gynaecological cancer diagnosis and treatment on body image. Body image is the subjective combination of thoughts, feelings, perceptions and attitudes a person holds about their physical self, including their shape, size and function.

Clinical trials Educate and support the patient who is considering, or is enrolled in, cancer clinical trials. Clinical trials are research studies involving human volunteers to evaluate the safety and effectiveness of new treatments, medicines, vaccines or medical devices, and may include pharmaceutical and non-pharmaceutical (such as lifestyle) interventions.

Cultural considerations Assess and address cultural considerations to ensure the provision of culturally safe care. Cultural considerations encompass diverse beliefs, communication styles, family structures and decision-making processes, perceptions of illness, language needs, use of traditional medicines, and gender roles and preferences.

Dental and oral health Educate the patient about the importance of dental and oral health whilst undergoing cancer treatment. Dental and oral health is care of the mouth, gums and teeth, and is crucial to prevent severe infections, manage painful side effects and maintain nutrition, as cancer treatments can weaken the immune system and damage oral tissues, often resulting in treatment delays.

Diagnosis understanding Assess the patient's and carer's understanding of the diagnosis, including disease type, location, stage/grade and test results. Comprehensive understanding improves patient outcomes, facilitates shared decision-making, reduces anxiety, and improves treatment adherence and overall quality of life.

Exercise and physical activity Assess the patient's current physical activity and engagement in exercise, educate about the benefits, and refer as necessary to physiotherapy or exercise physiology. Exercise is a safe and effective therapy for people with cancer and reduces cancer-related fatigue, eases treatment side effects, boosts mood and mental wellbeing, and improves physical function, bone density and sleep quality.

Family history Discuss and document the patient's family health history and assess genetic risk. Family history is a crucial tool for assessing cancer risk, as some cancers can be caused by inherited genetic mutations, and a detailed history can determine if genetic testing is required.

Fertility Assess the patient for the impact of proposed cancer treatments on fertility and facilitate timely referral to fertility specialists before treatment starts. Discuss contraception and family planning in relation to treatment. Cancer treatments can temporarily or permanently affect fertility by damaging reproductive organs, reducing egg quality, or causing premature menopause.

Finance and employment Assess the impact of cancer on the patient's financial and employment situation using a validated tool, and facilitate referral as required to support services, including social work. Cancer and its treatment can be a financial strain, caused by extra costs during and after treatment or loss of income, and some people may be discriminated against at work due to their cancer diagnosis.

Functional status Assess the patient's functional status using a validated tool such as the Eastern Cooperative Oncology Group (ECOG) scale. ECOG is a 0–5 scale used by clinicians to assess the functional ability of a person with cancer, and to guide appropriate treatment decisions.

General practitioner (GP) Facilitate communication between the general practitioner (GP) or primary health provider and the health service to ensure timely sharing of information, and ensure they have contact details for the service to enable rapid access back to the treatment centre. The GP plays a vital role in the cancer care team, from prevention, early detection, treatment support, survivorship and palliative care, including management of co-morbidities and supporting mental health.

Genetic testing and counselling Educate the patient regarding genetic testing and provide support to discuss risks, and consider the benefits and limitations. Genetic testing (or germline testing) for cancer assesses inherited gene mutations that increase cancer risk and guides treatment decisions for some gynaecological cancers.

Goals of care Support the patient and carers to ensure that goals of care are person-centred and facilitate shared decision-making that aligns medical treatment with a person's values, priorities and quality of life. Goals of care in cancer may focus on curing the disease, prolonging life or maximising quality of life, and can change throughout the patient's cancer journey.

Multidisciplinary team (MDT) meeting & involvement Actively contribute and advocate for the patient within MDT meetings and throughout the care trajectory. Nurses are vital members of the MDT, acting as patient advocates and providing holistic, person-centred insights to better coordinate clinical decisions and patient care.

Prognosis understanding Assess the patient's and carers' understanding of the prognosis and facilitate further discussion with the medical team as required. Understanding cancer prognosis is crucial for patients to make informed treatment decisions, plan for the future and manage expectations.

Psychological and emotional support Assess the psychological and emotional support needs of the patient and carers using validated tools and provide support and referrals to services as required. Understanding these needs helps ensure access to appropriate services, which can improve survival outcomes, enhance treatment adherence and reduce the risk of long-term mental health issues.

Sexual health Assess and discuss the impact of gynaecological cancers on the patient's sexual health, use validated screening tools to assess sexual function and refer to specialist services as required. Gynaecological cancers significantly affect sexual health, including physical and hormonal changes, psychological responses, fertility and contraception, and effects on relationships and intimacy.

Side-effect management Assess for and manage side effects of treatment in conjunction with the multidisciplinary team, using validated tools where indicated. Effective management of cancer treatment side effects is crucial to maintain treatment adherence, prevent complications and improve quality of life.

Skin and wound care Assess, manage and educate the patient on skin and wound care. Skin and wound care promotes skin integrity, alleviates symptoms, supports comfort, and is important to prevent infections, support surgical wound healing and manage side effects of treatment.

Social supports Assess the patient's current family and social supports and the need for referral for additional support. Family and social support can improve quality of life by providing essential resources to cope with stress, help manage treatment side effects and reduce emotional distress.

Symptom management Assess for and educate the patient on the symptoms of their disease and manage these in conjunction with the multidisciplinary team. The management of symptoms will depend on the goals of care (curative or palliative intent) but must always consider the patient's quality of life, function, distress and tolerance of treatments.

Transport and accommodation Assess the patient's transport and accommodation needs and facilitate access to available assistance. Transport and accommodation support through government-funded Patient Assisted Travel Schemes (PATS) is important, particularly for regional and rural patients, as it can directly affect access to treatment, lower financial burden and reduce stress.

Treatment adherence/compliance Assess the patient for adherence to treatment and seek to understand and address any barriers to engagement in optimal care. Treatment adherence is critical to achieve optimal prognosis and improved outcomes, whilst non-adherence can lead to disease progression and increased mortality.

Treatment induced menopause Discuss and educate the patient about expected treatment-induced menopause and facilitate management of symptoms. Consider referral to specialised menopause after cancer services if available. Treatment-induced menopause is the sudden cessation of ovarian function due to surgical or cancer treatments.

Treatment plan Ensure the patient understands their treatment plan, including the timing, duration and expected recovery from each treatment modality. A treatment plan outlines how a patient's cancer will be treated over time.

📌 PRACTICE RECOMMENDATIONS

Assess and support understanding of genomics relevant to a person’s diagnosis or genetic risk of a gynaecological cancer, and provide tailored clinical and psychosocial supportive care.

PRACTICE RECOMMENDATION 3 · GENOMICS
WHEN?

At key points such as pre-diagnosis, diagnosis, during treatment and during follow-up.

HOW?
  • Assess and discuss understanding of genetic risk, genomic testing and targeted therapy.
  • Provide tailored information, including written materials.
  • Facilitate access to genetic counselling and support to discuss risk and implications for family.

Offer and facilitate access to a specialist cancer nurse for all people with a gynaecological cancer.

PRACTICE RECOMMENDATION 4 · SPECIALIST NURSE ACCESS
WHEN?

At key points such as pre-diagnosis, diagnosis, during treatment and during follow-up. Continue to offer, even if the patient has previously declined specialist nurse referral.

HOW?
  • Offer and facilitate referral to a specialist cancer nurse with expertise in gynaecological cancers.
  • The nurse may be available through the treating centre, or through specialist cancer support services via the ACNNP, such as Ovarian Cancer Australia or the McGrath Foundation.

Screen and/or assess people with gynaecological cancers for determinants of health that may influence their cancer experience and the delivery of culturally safe and equitable care.

PRACTICE RECOMMENDATION 5 · HEALTH DETERMINANTS
WHEN?

An initial comprehensive screen or assessment as soon as possible from first contact. Review when there are changes in circumstance, health condition or transitions of care.

HOW?
  • Use a validated screening tool to assess needs, such as the Nursing Equity Assessment Tool (NEAT) or the GYN Distress Thermometer and Problem List.

Facilitate supportive care needs screening using patient-reported outcome measures (PROMs) to prioritise care that meets self-determined needs.

PRACTICE RECOMMENDATION 6 · SUPPORTIVE CARE NEEDS SCREENING
WHEN?

At a minimum, at key points such as pre-diagnosis, diagnosis, during treatment and during follow-up. Make contact as soon as possible after screening to manage any risk (e.g. high distress).

HOW?
  • Facilitate patients to complete a validated supportive care needs screening tool (e.g. GYN Distress Thermometer and Problem List).
  • Assess the results.
  • Prioritise and manage care according to identified needs.
  • Facilitate referrals as indicated.

Provide education and information for all patients at risk of treatment-induced menopause symptoms and evaluate symptoms. Refer to specialist menopause support for complex needs.

PRACTICE RECOMMENDATION 7 · MENOPAUSE SYMPTOMS
WHEN?

Before treatment starts and regularly during and after treatment, including risk-reducing surgery.

HOW?
  • Discuss possible menopausal symptoms.
  • Provide written information and facilitate access to credible online resources.
  • Evaluate symptoms using an assessment tool.
  • Advocate for and facilitate access to pharmacological and non-pharmacological management of symptoms.

Discuss current exercise and nutrition habits, provide education and set tailored goals to optimise exercise and nutrition during and after cancer treatment.

PRACTICE RECOMMENDATION 8 · EXERCISE AND NUTRITION
WHEN?

Before treatment starts, or as soon as possible. Review regularly during and beyond initial treatment.

HOW?
  • Assess current exercise habits and nutrition status using validated tools where available.
  • Discuss and provide information on exercise during and beyond cancer treatment and on external programs.
  • Facilitate goal setting, and review and adapt at regular intervals.
  • If indicated, refer to a dietitian and/or specialist exercise health professional.

Assess the current and future fertility impacts of gynaecological cancers and provide information and supportive care to facilitate informed decision-making.

PRACTICE RECOMMENDATION 15 · FERTILITY
WHEN?

As soon as possible after diagnosis and before treatment starts.

HOW?
  • Discuss the risks and effects of disease and treatment on fertility, and assess psychosocial impacts.
  • Provide counselling, education and support for decision-making, including decision-support tools where available.
  • Provide age-appropriate written materials to support discussions.
  • Offer and facilitate referral to a fertility clinic and for additional support, if indicated.
  • If appropriate, involve partners in information provision.

Recognise the central role of family, culture and community in the care of Aboriginal and Torres Strait Islander people with a gynaecological cancer, and incorporate these into assessment, treatment

PRACTICE RECOMMENDATION 16 · ABORIGINAL AND TORRES STRAIT ISLANDER PEOPLE
WHEN?

As soon as a person has identified as Aboriginal and/or Torres Strait Islander.

HOW?
  • Engage in cultural training and actively apply these learnings when caring for Aboriginal and/or Torres Strait Islander people.
  • Seek permission to refer to an Aboriginal or cultural liaison officer, nurse navigator or other support role, if available.

Advocate within the multidisciplinary team on patients’ supportive care needs and goals of care, and advise on strategies to reduce impacts.

PRACTICE RECOMMENDATION 17 · ADVOCACY WITHIN MULTIDISCIPLINARY CARE
WHEN?

At all points of care, including during and after multidisciplinary team meetings.

HOW?
  • All nurses: provide patient advocacy at all stages of care.
  • At the MDT meeting, a specialist gynaecological cancer nurse should attend and represent the patient’s supportive care needs and goals of care, contributing insight into psychosocial, physical, cultural or practical considerations that may influence treatment planning.
  • Ensure holistic needs are addressed, including referral to allied health, specialist nursing or community support services.
  • Continue advocacy outside the meeting by supporting the patient’s understanding of MDT decisions and coordinating follow-up actions.

Support patients’ understanding of clinical trials and, where indicated, advocate for and coordinate referral to appropriate trials.

PRACTICE RECOMMENDATION 18 · CLINICAL TRIALS
WHEN?

From diagnosis and at key points throughout treatment and beyond.

HOW?
  • Discuss clinical trials and provide, or direct patients to, credible information sources.
  • Assess supportive care needs relevant to trial participation.
  • Provide emotional and psychosocial care, whether or not trials are available for the patient.

🔬 TUMOUR-SPECIFIC CONSIDERATIONS

Cervical cancer

  • Assess genetic testing/molecular profiling history and facilitate testing if the patient is eligible
  • Provide education on the molecular profile (i.e. HER2 status) and implications for treatment options, if appropriate
  • Consider eligibility for tumour-agnostic therapies
  • Consider availability and eligibility for clinical trials

Gestational trophoblastic disease/neoplasia

  • Targeted therapies are typically not used

Ovarian cancers (including fallopian tube and primary peritoneal cancers)

  • Assess genetic testing/molecular profiling history and facilitate testing if the patient is eligible
  • Identify if the patient is eligible for PARP inhibitor therapy and provide patient education on its mechanism of action, use and side effects
  • Consider patient eligibility for clinical trials
  • Discuss the need for and use of antiemetics to manage side effects of targeted therapies
  • Discuss and assess for cancer-related fatigue
  • Refer to Ovarian Cancer Australia for additional specialist supportive care

Uterine cancers (including endometrial cancer)

  • Assess genetic testing/molecular profiling history and facilitate testing if the patient is eligible
  • Provide education on the molecular profile (i.e. MMR status and HER2 status) and implications for treatment options, if appropriate
  • Provide clear information about oral hormone and targeted therapies and the importance of adhering to the prescribed regimen. Consider structured ongoing support to enhance adherence
  • Consider eligibility for tumour-agnostic therapies
  • Consider availability and eligibility for clinical trials

Vaginal cancer

  • Consider availability and eligibility for clinical trials

Vulval cancer

  • Consider availability and eligibility for clinical trials

🌱 LIVING WELL AND DELIVERY CONSIDERATIONS

LIVING WELL
  • Encourage ongoing GP contact for comorbid condition management, immunisation, screening, chronic disease, mental health care plan, and other health concerns
  • Offer health promotion and lifestyle maintenance solutions
  • Facilitate healthy lifestyle modifications
  • Discuss and facilitate advance care planning for patients with a life-limiting illness
  • Survivorship Care Plan
DELIVERY CONSIDERATIONS

Interpreter services (inc Auslan) Facilitate and utilise professional medical interpreter services for all patients who communicate or prefer to communicate in languages other than English. Avoid the use of family members as interpreters and, where possible, pre-brief the interpreter if complex medical language or sensitive conversations are required. Optimal use of interpreter services will enable clear and thorough information exchange between patients and health care professionals, ensuring patients are fully informed and included in decision making about their care.

Hearing status Assess the patient's hearing and adjust care provision for patients with hearing impairment including use of hearing and visual aids, and Auslan interpreter as required. Sign language interpreters are vital to ensure accurate communication, and accessibility for hearing impaired individuals.

Vision status Assess the patient for vision impairment and adjust care provision including use of vision, auditory and mobility aids. Vision impairment is the reduced ability to see that cannot be fully corrected with glasses or contact lenses, and may impact activities of daily living such as reading and driving.

Trauma-informed care Provide trauma-informed care to all people with a gynaecological cancer. Trauma-informed care is a person-centred approach to care that recognises the widespread impact of trauma and actively prevents re-traumatisation through empowering patients and providing physical and emotionally safe care.

Learning style Assess and discuss the patient's preferred learning style and needs for receiving education and information. Common adult learning styles include visual, auditory, and kinaesthetic or a combination of these and information provision should be offered in a way that best meets their needs and preferences.

Health literacy Assess the patient's health literacy levels and adapt education and information provision to meet their needs and preferences. Health literacy is the ability to access, understand and apply health information to make informed decisions and manage health.

Accessibility and support for priority groups Identify and support the individual needs of people with cancer from priority population groups to enable access to optimal cancer care including Aboriginal and Torres Strait Islander people, culturally and linguistically diverse people, LGBTQIA+ people, older and younger people, those living in rural and remote areas, people experiencing mental illness or disability, or those living in low socioeconomic circumstances. These priority population groups are known to experience poorer cancer outcomes and require a person-centred, targeted approach to care to achieve equitable outcomes.

Appointment type (face to face/telehealth) Discuss and facilitate the most appropriate appointment type for the patient with consideration of the need for physical examination, the delivery of sensitive information, access to technology and skills to use, distance the patient needs to travel and availability of transport and the need for interpreters and/or support people. Understanding patients' needs and preferences and balancing this with clinical needs will ensure the best appointment type is selected to meet their needs.

Communication with treatment team & general practitioner (GP) Ensure timely and accurate communication of treatment plan and any changes to care to enable continuity of care between the cancer team and general practitioner. Clearly communicate escalation pathways from primary care back to the treatment team and ensure the patient consents to the sharing of this information. Timely and accurate communication between healthcare settings reduces the burden on patients to communicate their story repeatedly.

More comprehensive care considerations →

ABORIGINAL AND TORRES STRAIT ISLANDER PEOPLE

  • Establish cultural preferences and sensitivity regarding Women’s Business
  • Involve and support extended family, kin and community (mob)
  • Allocate adequate time to build rapport at every interaction
  • Ensure culturally safe communication and information (verbal and written), appropriate to health literacy level
  • Recognise connection to Country and facilitate care on Country where possible
  • Consider the use of cultural or bush medicine, or traditional healers that may be accessed by the person
  • Seek permission to refer to an Aboriginal or cultural liaison officer, nurse navigator or other support role if available
  • Ensure sensitivity and acknowledgement around Sorry Business

More detail in Comprehensive Care Considerations →

📚 MORE INFORMATION

For nurses

Points for MDT discussion
  • Functional status
  • Treatment goals
  • Psychosocial needs
  • Referral for geriatric oncology assessment, if appropriate
  • Facilitate communication with GP
  • Clinical trial options
Resources for nurses
  • Optimal Care Pathways
  • Targeted therapy – Cancer Australia
  • Gynaecological cancer medical oncology protocols – eviQ
  • Fatigue (1793) – eviQ
  • Clinical Trials Resource Hub – Ovarian Cancer Australia
  • PARP inhibitors and ovarian cancer – ANZGOG

More resources →

Assessment tools

More assessment tools →

For patients and carers

What is next for the patient? Who needs to know?
  • Communicate changes in plan to the primary care provider (GP)
  • Discuss early reporting of side effects with the patient
  • Provide symptom and urgent review clinic (SURC) contact details, if available
  • Provide contact details for the service
  • Assess understanding of the blood testing required
  • Provide the patient with a chemotherapy alert card
Common referrals
  • Symptom and urgent review clinics (SURC)
  • Occupational therapy for fatigue management strategies
  • Exercise physiologist
  • Pharmacist
Resources for patients
  • Understanding targeted therapy – Cancer Council
  • Oral anti-cancer medicines (3086) – eviQ
  • Managing the side effects of anti-cancer medicines (3088) – eviQ
  • Jean Hailes for Women’s Health
  • Sexuality, body image, relationships and ovarian cancer – Ovarian Cancer Australia
  • Carers Australia
  • Understanding targeted therapy: information for patients – eviQ
  • Look Good Feel Better
  • Cancer, work and you – Cancer Council
  • Cervical cancer support booklet – Australian Cervical Cancer Foundation
  • Rare Cancers Australia
  • Ovarian Cancer Australia
  • Gather My Crew

More resources →

First published: October 2026 · Last updated: October 2026